Most Recent
Apotex sued by former managing director over unpaid bonuses, leave
A former managing director of global drug giant Apotex is suing his old employer over $226,000 in bonuses and $175,000 in leave he claims were not paid when he was made redundant in September 2019.
Witness who won’t undergo quarantine can testify by video link in ex-Quintis boss’ trial
A judge has allowed a key US-based witness in ASIC's case against former Quintis director Frank Wilson who will not submit to 14 days in hotel quarantine to give evidence by video link.
Class action members having ‘second thoughts’ after payments from Monash IVF, court told
Monash IVF patients who accuse the company of destroying viable embryos are having "second thoughts" after accepting payment offers by the fertility clinic and signing away their rights to participate in a class action, a Victoria Supreme Court judge has heard.
Negligence claims in COVID-19 class actions should be axed, aged care providers tell court
Two Melbourne-based aged care providers want negligence claims that are unrelated to COVID-19 removed from class actions over their handling of the pandemic, in a move that may exclude a “very large number” of group members from the proceedings.
ACCC frowns on Smile Direct’s health care coverage claims
The Australian Competition and Consumer Commission has taken legal action against international dental care company Smile Direct Club for allegedly misleading tens of thousands of consumers with claims they would be eligible for private health insurance coverage for their aligner teeth straighteners.
Vic hospital operator points finger at junior doctors in underpayments class action
Victorian public healthcare provider Peninsula Health has hit back at an underpayments class action brought by junior doctors, saying it was up to them to seek authorisation and payment for any overtime hours worked.
Full Court upholds Sequenom’s win in patent battle over prenatal genetic tests
The Full Federal Court has upheld US biotech company Sequenom's  patent for a noninvasive prenatal genetic test, rejecting rival Ariosa Diagnostic's argument that the patent merely described a way to extract incorporeal genetic information.
Biogen sues to fend off generic competition to MS drug Tecfidera
Switzerland-based Biogen has sued generic drug maker MSN Laboratories for allegedly threatening to infringe the patent for its top-selling oral MS drug Tecfidera.
Judge warns ‘enough’s enough’ in fight for damages over delayed Abilify generic
A judge has given Generic Health more time to file its evidence in a multimillion-dollar dispute with drug makers Otsuka and Bristol-Myers Squibbs over the delayed launch of generic versions of their antipsychotic drug Abilify, but warned there had to be a cut-off point for preparing the decade-long dispute for trial.
Jury finds Country Care not guilty in first criminal cartel case against Australian biz
The ACCC has suffered a stinging defeat in its criminal cartel action against mobility equipment provider Country Care, its CEO and a former employee, with a jury handing down not guilty verdicts on all eight charges in the case.